On the road to PARPi-platin.
Affiliation of author: University of Arizona Cancer Center, Tucson, AZ. mbookman@email.arizona.edu.
Michael A
MA
Bookman
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019313:BRCA1 Protein / Q000235:genetics*; D024682:BRCA2 Protein / Q000235:genetics*; D004249:DNA Damage; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D009154:Mutation; D060787:Neoplasm Grading; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D017671:Platinum Compounds / Q000008:administration & dosage; D011064:Poly Adenosine Diphosphate Ribose / Q000008:administration & dosage
D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human; D017671:Platinum Compounds; D011064:Poly Adenosine Diphosphate Ribose